17-alpha-hydroxyprogesterone caproate treatment of gynecologic cancer.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D000367:Age Factors; D000368:Aged; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D008875:Middle Aged; D011379:Prognosis; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000401:mortality; D014626:Vaginal Smears
D006908:Hydroxyprogesterones